GeneThera, Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fe992181-2078-4fbf-83f1-59aa7626096b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-1.0M | 2021-01-01 – 2021-12-31 | evidence 0001477932-22-002272 |
| FY 2020 | $-740.6k | 2020-01-01 – 2020-12-31 | evidence 0001199835-21-000184 |
| FY 2019 | $-739.2k | 2019-01-01 – 2019-12-31 | evidence 0001199835-20-000136 |
| FY 2018 | $-3.9M | 2018-01-01 – 2018-12-31 | evidence 0001654954-20-001984 |
| FY 2017 | $-605.7k | 2017-01-01 – 2017-12-31 | evidence 0001654954-20-001984 |
| FY 2016 | $-605.7k | 2016-01-01 – 2016-12-31 | evidence 0001017110-18-000029 |
| FY 2015 | $-680.1k | 2015-01-01 – 2015-12-31 | evidence 0001017110-18-000029 |
| FY 2014 | $-608.6k | 2014-01-01 – 2014-12-31 | evidence 0001017110-16-000028 |
| FY 2013 | $-1.1M | 2013-01-01 – 2013-12-31 | evidence 0001504412-14-000110 |
| FY 2012 | $-1.8M | 2012-01-01 – 2012-12-31 | evidence 0001504412-13-000152 |
| FY 2011 | $-1.1M | 2011-01-01 – 2011-12-31 | evidence 0001504412-13-000152 |
| FY 2010 | $482.9k | 2010-01-01 – 2010-12-31 | evidence 0001096906-12-000928 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).